Oral pemphigus vulgaris: A case-based rheumatological and immunological perspectives on a rare autoimmune mucocutaneous disease

Authors

  • Ankur Dalal Wellness Clinic for Rheumatic & Musculoskeletal Medicine

DOI:

https://doi.org/10.15305/ijrci/v9i1/354

Keywords:

Acantholysis, anti-desmoglein3 antibody, rheumatic disease, recurrent oral ulcers

Abstract

A 52-year-old female patient was referred for suspected rheumatic or connective tissue disease due to one-year history of recurrent oral ulcers along with recent history of nasal ulcers, erythematous rash, puffy fingers, raised erythrocyte sedimentation rate, raised c-reactive protein, and acute inflammatory exudates on biopsy of buccal mucosal ulcers. Her intra-oral examination revealed ulcerative lesions in the mouth. Her anti-nuclear antibody (ANA) by indirect immunofluorescence showed intensity of +2 and cytoplasmic pattern. The repeat deep biopsy from oral lesions was done in view of multiple recurrent inflammatory oral ulcers, non-supportive ANA test, and bleeding with peeling of mucosal surface from oral ulcers on manipulation (Nikolsky’s sign). The histopathological examination showed acantholysis. Her test for anti-desmoglein3 antibody was strongly positive and was diagnosed with oral pemphigus vulgaris (PV). Most of the times, PV is encountered by a dermatologist, but patients with only oral involvement may end up consulting a physician or rheumatologist as a suspected rheumatic or connective tissue disease due to the underlying inflammatory or autoimmune nature. The present case-based review revisits this rare chronic inflammatory autoimmune mucocutaneous disease and provides a recent review of literature based on rheumatological and immunological perspectives.

References

Grando SA. Pemphigus autoimmunity: Hypotheses and realities. Autoimmunity 2012; 45:7‑35..

Kanwar AJ, De D. Pemphigus in India. Indian J Dermatol Venereol Leprol 2011; 77:439 49.

Ohta M, Osawa S, Endo H, Kuyama K, Yamamoto H, Ito T. Pemphigus Vulgaris confined to gingiva: a case report. International journal of dentistry. Vol 2011, article id 207153.

Rai A, Arora M, Naikmasur V, Sattur A, Malhotra V. Oral Pemphigus Vulgaris: Case Report Ethiop J Health Sci. 2015; 25(4): 367-72.

Mohan M, Prasad BR, Shetty P, Sharma N. Oral Pemphigus: Case Report & Treatment Strategies. Int. J. Adv. Res. 2016; 5(1): 2578-2580.

Matute GR, Alonso ER. Recurrent Aphthous Stomatitis in Rheumatology. Reumatol Clin. 2011; 7(5):323–328.

Kumar B. Oral ulcers. The National Journal of India. 1993; 6(5): 221-27.

Mortazavi H, Safi Y, Baharvand M, Rahmani S. Diagnostic features of common oral ulcerative lesions: an updated decision tree. International journal of dentistry. 2016 Oct 3;2016.

Lalla RV, Saunders DP, Peterson DE. Chemotherapy or radiation induced oral mucositis. Thomas KT, Feder Jr HM, Lawton AR, Edwards KM. Periodic fever syndrome in children. J Pediatr. 1999; 135:15–21.

Thomas KT, Feder Jr HM, Lawton AR, Edwards KM. Periodic fever syndrome in children. J Pediatr. 1999; 135:15–21.

Moreland LW, Brick JE, Kovach RE, DiBartolomeo AG, Mullins MC. Acute febrile neutrophilic dermatosis (Sweet’s syndrome): a review of the literature with emphasis on musculoskeletal manifestations. Semin Arthritis Rheum. 1988; 17:143–55.

Firestein GS, Gruber HE, Weisman MH, Zvaifler NJ, Barber J, O’Duffy JD. Mouth and genital ulcers with inflamed cartilage: MAGIC syndrome, five patients with features of relapsing polychondritis and Behcet’s disease. Am J Med.1985; 79:65–72.

Amagai M, Ikeda S, Shimizu H, Iizuka H, Hanada K, Aiba S, et al. A randomized double blind trial of intravenous immunoglobulin for pemphigus. J Am Acad Dermatol 2009; 60:595-603.

Singh S. Evidence-based treatments for pemphigus vulgaris, pemphigus foliaceus, and bullous pemphigoid: A systematic review. Indian J Dermatol Venereol Leprol 2011; 77:456-69.

Pasricha JS, Gupta R. Pulse therapy with dexamethasone cyclophosphamide in pemphigus. Indian J Dermatol Venereol Leprol. 1984; 50:199‑203.

Kanwar AJ, Vinay K. Treatment of pemphigus: An Indian perspective. Indian J Dermatol Venereol Leprol 2014; 80:285-8.

Leventhal JS, Sanchez MR. Is it times to re-evaluate the treatment of pemphigus? J Drugs Dermatol. 2012; 11:1200‑6.

Daniel BS, Hertl M, Werth VP, Eming R, Murrell DF. Severity score indexes for blistering diseases. Clin Dermatol. 2012 ; 30(1): 108–113.

Rosenbach M, Murrell DF, Bystryn JC, et al. Reliability and convergent validity of two outcome instruments for pemphigus. J Invest Dermatol. 2009; 129:2404–10.

Downloads

Published

03-02-2022

Issue

Section

Case Studies